Last update 29 Aug 2025

HLCR-011

Overview

Basic Info

Drug Type
Induced pluripotent stem cells (iPSC)
Synonyms
HLCR 011
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Congenital DisordersEye DiseasesOther Diseases
Active Indication
Age Related Macular DegenerationWet Macular DegenerationRetinitis Pigmentosa
Inactive Indication-
Originator Organization
Healios KKHealios KK
Active Organization
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.Healios KKHealios KK
Inactive Organization-
License Organization
Healios KKHealios KKSumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with HLCR-011
JPRN-jRCT2073230077
/ RecruitingPhase 1/2IIT
A Phase I/II Study of Evaluate the Safety and Efficacy of HLCR011 in Patients with Retinal Pigment Epithelium Tear
100 Clinical Results associated with HLCR-011
Login to view more data
100 Translational Medicine associated with HLCR-011
Login to view more data
100 Patents (Medical) associated with HLCR-011
Login to view more data
100 Deals associated with HLCR-011
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Age Related Macular DegenerationClinical
Japan
Healios KKHealios KK
-
Wet Macular DegenerationPreclinical
Japan
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
-
Wet Macular DegenerationPreclinical
Japan
Healios KKHealios KK
-
Retinitis PigmentosaDiscovery
Japan
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free